Compugroup Medspadr 1 Stock Return On Asset

COPA Stock  EUR 21.20  0.40  1.85%   
COMPUGROUP MEDSPADR 1 fundamentals help investors to digest information that contributes to COMPUGROUP MEDSPADR's financial success or failures. It also enables traders to predict the movement of COMPUGROUP Stock. The fundamental analysis module provides a way to measure COMPUGROUP MEDSPADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COMPUGROUP MEDSPADR stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

COMPUGROUP MEDSPADR 1 Company Return On Asset Analysis

COMPUGROUP MEDSPADR's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current COMPUGROUP MEDSPADR Return On Asset

    
  0.031  
Most of COMPUGROUP MEDSPADR's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, COMPUGROUP MEDSPADR 1 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, COMPUGROUP MEDSPADR 1 has a Return On Asset of 0.031. This is 100.35% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The return on asset for all Germany stocks is 122.14% lower than that of the firm.

COMPUGROUP Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses COMPUGROUP MEDSPADR's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of COMPUGROUP MEDSPADR could also be used in its relative valuation, which is a method of valuing COMPUGROUP MEDSPADR by comparing valuation metrics of similar companies.
COMPUGROUP MEDSPADR is currently under evaluation in return on asset category among its peers.

COMPUGROUP Fundamentals

About COMPUGROUP MEDSPADR Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze COMPUGROUP MEDSPADR 1's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of COMPUGROUP MEDSPADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of COMPUGROUP MEDSPADR 1 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in COMPUGROUP Stock

COMPUGROUP MEDSPADR financial ratios help investors to determine whether COMPUGROUP Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in COMPUGROUP with respect to the benefits of owning COMPUGROUP MEDSPADR security.